Septicemic Melioidosis in a Diabetic Patient from a Tertiary Care Centre in Kerala

Are Burkholderia Emerging Pathogens in patients with underlying morbidity: A case series

“… Case 3 Susceptible – to meropenem, ceftazidime, doxycycline, amoxicillin-clavulanate and co-trimoxazole. Case 2 IV ceftazidime 2g thrice daily for a duration of two weeks, advice to continue doxycycline 100mg twice daily for 3 months Case 3 IV ceftazidime 2g thrice daily and IV meropenem 2g e twice daily combination therapy followed by oral cotrimoxazole at 480mg twice a day for six months Both cases were Lost to follow up Reports from India [ 11 ] Kerala B. pseudomallei Fever with altered sensorium Farmer IV meropenem 1g eight hourly Recovered Reports from worldwide [ 12 ] Colombia B. pseudomallei Fever with chills, rigor and right leg pain Gardner IV meropenem 2g 12 hourly and vancomycin 1g 12 hourly Recovered SSI/wound infection Our case Case 4 Case 5 Chennai B. cepacia B. cenocepacia Right lower limb fracture treated with emergency surgery presented with SSI on 5th post-operative day Multiple open fracture treated with emergency surgery presented with SSI Shopkeeper Field worker Susceptible- ceftazidime, Minocycline, cotrimoxazole, Levofloxacin, Meropenem IV Meropenem 2g twice daily two weeks and to continue oral co-trimoxazole 480mg twice daily for six months. Patient completely recovered after follow-up remained free of infection.…”